Pharmanutra Logo

Pharmanutra

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaNutra S.p.A., established in 2003, is an Italian company specializing in the research, development, and marketing of nutraceutical products, food supplements, and medical devices. The company focuses on creating innovative and scientifically-backed solutions, particularly for nutritional deficiencies in minerals and vitamins, as well as for muscle and joint health. PharmaNutra manages the entire production cycle, from proprietary raw materials to the finished product, ensuring high standards of efficacy and safety. The group also develops and sells pharmaceuticals, distinguishing itself through a strong emphasis on scientific research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pharmanutra. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 18:05
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
English 465.8 KB
2025-08-04 18:04
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
Italian 259.1 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
Italian 189.4 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
English 241.0 KB
2025-05-27 10:47
Investor Presentation
MIDCAP Road Show - Paris
English 3.4 MB
2025-05-15 15:26
Registration Form
Statuto sociale aggiornato
Italian 295.1 KB
2025-05-15 15:25
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
Italian 9.4 MB
2025-05-15 15:23
Post-Annual General Meeting Information
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
Italian 172.3 KB
2025-05-14 11:46
Quarterly Report
Interim Management report as at March 31st, 2025
English 1.7 MB
2025-05-14 11:45
Management Discussion and Analysis
Resoconto Intermedio di gestione al 31 Marzo 2025
Italian 1.4 MB
2025-05-14 11:44
Report Publication Announcement
Avviso deposito Rendiconto Intermedio di gestione al 31 marzo 2025 || Notice of…
Italian 177.0 KB
2025-05-12 17:30
Earnings Release
Pharmanutra: CdA approva il Resoconto intermedio di gestione al 31 marzo 2025
Italian 282.7 KB
2025-05-12 17:30
Quarterly Report
Pharmanutra: BoD approves the Intermin management report as of March 31, 2025
English 349.0 KB
2025-05-06 17:02
Director's Dealing
Allegato 3F - Aprile 2025
Italian 92.0 KB
2025-04-22 16:41
Post-Annual General Meeting Information
PHARMANUTRA: Voting Summary Report
English 341.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Antibiotice S.A. Logo
Manufactures FDA-approved generic drugs, sterile injectables, and APIs for global markets.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB